Blank-check company headed by former Trump official to bring Cambridge biotech public for $280 million


The special purpose acquisition company taking Aprinoia Therapeutics public for $280 million was founded by Wilbur Ross, the former U.S. Secretary of Commerce under the Trump administration.

Previous Charlotte real estate company Coldwell Banker Commercial MECA to rebrand, ending 20-year affiliation
Next Clearwater investor barred from penny stocks after pump-and-dump scheme

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *